MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$13,677K
Net Income
-$30,340K
Net Profit Margin
-221.83%
EPS
-$0.02
Unit: Thousand (K) dollars
Revenue Breakdown
Revenue from contract with custo...
Revenue from contract with custo...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-06-30
2025-03-31
2024-12-31
2024-09-30
Total revenue
13,677
7,285
-75,926*
40,901
Selling, general and administrative
18,485
23,282
23,430*
21,277
Research and development
22,979
28,857
48,076*
34,304
Impairment of long-lived assets
-
-
2,600*
-
Cost of goods sold
2,501
879
18*
-
Total operating expenses
43,965
53,018
74,124*
55,581
Interest income, debt securities, available-for-sale, operating
-
-
-
2,096
(loss)/profit from operations
-30,288
-45,733
-150,050*
-14,680
Other income (expense), net
1,289
-305
2,168*
-3,093
Interest income
233
910
1,649*
-
Interest expense
962
1,881
896*
1,109
(loss)/profit before income tax expense
-29,728
-47,009
-147,129*
-16,786
Income tax expense
612
575
1,541*
831
Net (loss)/profit attributable to ordinary shareholders
-30,340
-47,584
-148,670
-17,617
Basic EPS
-0.02
-0.03
-0.101
-0.01
Diluted EPS
-0.02
-0.03
-0.103
-0.01
Basic Average Shares
1,584,522,868
1,542,159,622
1,473,286,742
1,534,613,977
Diluted Average Shares
1,584,522,868
1,542,159,622
1,447,634,805
1,534,613,977
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net (loss)/profit
attributable to ordinary...
-$30,340K
(-143.64%↓ Y/Y)
(loss)/profit before income
tax expense
-$29,728K
(-142.44%↓ Y/Y)
Income tax expense
$612K
(16.35%↑ Y/Y)
Other income
(expense), net
$1,289K
(159.36%↑ Y/Y)
Revenue from contract
with customer,...
$11,078K
Revenue from contract
with customer,...
$2,599K
Interest income
$233K
(loss)/profit from operations
-$30,288K
(-144.09%↓ Y/Y)
Total revenue
$13,677K
(-89.33%↓ Y/Y)
Interest expense
$962K
(82.89%↑ Y/Y)
Total operating
expenses
$43,965K
(-26.15%↓ Y/Y)
Research and development
$22,979K
(-43.19%↓ Y/Y)
Selling, general and
administrative
$18,485K
Cost of goods sold
$2,501K
Buy us a coffee
Adaptimmune Therapeutics PLC (ADAP)
Adaptimmune Therapeutics PLC (ADAP)